Inactive Instrument

News Axovant Sciences Ltd Nyse

Equities

AXON

BMG0750W1047

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	Feb. 02	GL
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	Feb. 02	AQ
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	23-04-06	AQ
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index	23-03-27	CI
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index	23-03-22	CI
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	23-03-15	PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-03-15	AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-14	AQ
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours	22-12-14	MT
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	22-12-14	GL
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	22-12-14	PU
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-12-14	AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-10	AQ
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	22-11-10	AQ
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	22-09-14	PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-09-14	AQ
Sio Gene Therapies : Announces Fiscal First Quarter 2022 Financial Results - Form 8-K	22-08-11	PU
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Axovant Sciences Ltd Nyse

Equities

AXON

BMG0750W1047

Summary

Filters